iCAD plans to supply lung cancer software

July 16, 2004

Software developer iCAD and image processing specialist TeraRecon have signed a nonexclusive product licensing and distribution agreement under which TeraRecon will develop a new server-based product offering to include iCAD lung cancer detection,

Software developer iCAD and image processing specialist TeraRecon have signed a nonexclusive product licensing and distribution agreement under which TeraRecon will develop a new server-based product offering to include iCAD lung cancer detection, analysis, and tracking software. Product release is expected in 2005. The stand-alone server product will work in concert with existing PACS and DICOM review equipment, as well as other products in the TeraRecon Aquarius product line. The three-year agreement provides for worldwide distribution through TeraRecon's direct sales force, independent resellers/distributors, and OEM partnerships. The companies have agreed to work together to obtain the FDA approvals necessary for U.S. distribution.